Hybrid Dextran-gadolinium Nano-suitcases as High-relaxivity MRI Contrast Agents
English
Hybrid Dextran-gadolinium Nano-suitcases as High-relaxivity MRI Contrast Agents
-
-
-
[1]
Kim J. H., Park K., Nam H. Y., Lee S., Kim K., Kwon I. C.. Polymers for bioimaging[J]. Prog. Polym. Sci., 2007, 32(8): 1031-1053.
-
[2]
de Leon-Rodriguez L. M., Lubag A. J. M., Malloy C. R., Martinez G. V., Gillies R. J., Sherry A. D.. Responsive MRI agents for sensing metabolism in vivo[J]. Acc. Chem. Res., 2009, 42(7): 948-957. doi: 10.1021/ar800237f
-
[3]
Darras V., Nelea M., Winnik F. M., Buschmann M. D.. Chitosan modified with gadolinium diethylenetriaminepentaacetic acid for magnetic resonance imaging of DNA/chitosan nanoparticles[J]. Carbohydr. Polym., 2010, 80(4): 1137-1146. doi: 10.1016/j.carbpol.2010.01.035
-
[4]
van der Elst L., Raynaud J. S., Vives V., Santus R., Louin G., Robert P., Port M, Corot C., Muller R.. Comparative relaxivities and efficacies of gadolinium-based commercial contrast agents[J]. Proceedings of the 21st Annual Meeting of ISMRM., 2013, : .
-
[5]
Soleimani A., Martínez F., Economopoulos V., Foster P. J., Scholl T. J., Gillies E. R.. Polymer cross-linking:a nanogel approach to enhancing the relaxivity of MRI contrast agents[J]. J. Mater. Chem. B, 2013, 1(7): 1027-1034. doi: 10.1039/C2TB00352J
-
[6]
Noh Y. W., Kong S. H., Choi D. Y., Park H. S., Yang H. K., Lee H. J., Kim H. C., Kang K. W., Sung M. H., Lim Y. T.. Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping[J]. ACS Nano, 2012, 6(9): 7820-7831. doi: 10.1021/nn301949y
-
[7]
Dai T., Zhou S., Yin C., Li S., Cao W., Liu W., Sun K., Dou H., Cao Y., Zhou G.. Dextran-based fluorescent nanoprobes for sentinel lymph node mapping[J]. Biomaterials, 2014, 35(28): 8227-8235. doi: 10.1016/j.biomaterials.2014.06.012
-
[8]
Li Y., Beija M., Laurent S., Elst L. V., Müler R. N., Duong H. T., Lowe A. B., Davis T. P., Boyer C.. Macromolecular ligands for gadolinium MRI contrast agents[J]. Macromolecules, 2012, 45(10): 4196-4204. doi: 10.1021/ma300521c
-
[9]
Caravan P.. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents[J]. Chem. Soc. Rev., 2006, 35(6): 512-523. doi: 10.1039/b510982p
-
[10]
Casali C., Janier M., Canet E., Obadia J. F., Benderbous S., Corot C., Revel D.. Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion[J]. Acad. Radiol., 1998, 5: S214-S218. doi: 10.1016/S1076-6332(98)80109-8
-
[11]
Jacques V., Desreux J.. New classes of MRI contrast agents[J]. Contrast Agents I, 2002, : 123-164.
-
[12]
Major J. L., Meade T.J.. Bioresponsive, cell-penetrating, and multimeric MR contrast agents[J]. Acc. Chem. Res., 2009, 42(7): 893-903. doi: 10.1021/ar800245h
-
[13]
Liu Q., Zhu H., Qin J., Dong H., Du J.. Theranostic vesicles based on bovine serum albumin and poly(ethylene glycol)-block-poly(L-lactic-co-glycolic acid) for magnetic resonance imaging and anticancer drug delivery[J]. Biomacromolecules, 2014, 15(5): 1586-1592. doi: 10.1021/bm500438x
-
[14]
Liu Q., Chen S., Chen J., Du J.. An asymmetrical polymer vesicle strategy for significantly improving T1 MRI sensitivity and cancer-targeted drug delivery[J]. Macromolecules, 2015, 48(3): 739-749. doi: 10.1021/ma502255s
-
[15]
Shalgunov V., Zaytseva-Zotova D., Zintchenko A., Levada T., Shilov Y., Andreyev D., Dzhumashev D., Metelkin E., Urusova A., Demin O.. Comprehensive study of the drug delivery properties of poly(L-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice[J]. J. Control. Release, 2017, : .
-
[16]
Zhang Q. L., Wang H. Y., Ge C. C., Duncan J., He K. H., Adeosun S. O., Xi H. X., Peng H. T., Niu Q.. Alumina at 50 and 13 nm nanoparticle sizes have potential genotoxicity[J]. J. Appl. Toxicol., 2017, 37: 1053-1064. doi: 10.1002/jat.v37.9
-
[17]
Wang L. Y., Huang J., Chen H. B., Wu H., Xu Y. L., Li Y. C., Yi H., Wang Y. A., Yang L., Mao H.. Exerting enhanced permeability and retention effect driven delivery by ultrafine iron oxide nanoparticles with T1-T2 switchable magnetic resonance imaging contrast[J]. ACS Nano, 2017, 11(5): 4582-4592. doi: 10.1021/acsnano.7b00038
-
[18]
Taylor K. M. L., Kim J. S., Rieter W. J., An H., Lin W., Lin W. B.. Mesoporous silica nanospheres as highly efficient MRI contrast agents[J]. J. Am. Chem. Soc., 2008, 130(7): 2154-2155. doi: 10.1021/ja710193c
-
[19]
Godin B., Tasciotti E., Liu X. W., Serda R. E., Ferrari M.. Multistage nanovectors:from concept to novel imaging contrast agents and therapeutics[J]. Acc. Chem. Res., 2011, 44(10): 979-989. doi: 10.1021/ar200077p
-
[20]
Chen K. J., Wolahan S. M., Wang H., Hsu C. H., Chang H. W., Durazo A., Hwang L. P., Garcia M. A., Jiang Z. K., Wu L.. A small MRI contrast agent library of gadolinium(ó)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity[J]. Biomaterials, 2011, 32(8): 2160-2165. doi: 10.1016/j.biomaterials.2010.11.043
-
[21]
Liu Z. H., Jiao Y. P., Wang Y. F., Zhou C. R., Zhang Z. Y.. Polysaccharides-based nanoparticles as drug delivery systems[J]. Adv. Drug Deliv. Rev., 2008, 60(15): 1650-1662. doi: 10.1016/j.addr.2008.09.001
-
[22]
Hu Y., Li Y., Xu F. J.. Versatile Functionalization of polysaccharides via polymer grafts:from design to biomedical applications[J]. Acc. Chem. Res., 2017, 50(2): 281-292. doi: 10.1021/acs.accounts.6b00477
-
[23]
Mizrahy S., Peer D.. Polysaccharides as building blocks for nanotherapeutics[J]. Chem. Soc. Rev., 2012, 41(7): 2623-2640. doi: 10.1039/C1CS15239D
-
[24]
Du H. J., Shen Y. C., Liu Y. P., Han L., Zheng Y., Yan G. P., Tu Y. Y., Wu J. Y., Guo Q. Z., Zhang Y. F., Xia X. T., Lan X. L., Xia X. T.. Dextran gadolinium complex containing folate groups as a potential magnetic resonance imaging contrast agent[J]. Chinese J. Polym. Sci., 2015, 33(9): 1325-1333. doi: 10.1007/s10118-015-1681-4
-
[25]
Klaveness J.. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging:synthesis and relaxation properties[J]. Carbohydr. Res., 1991, 214(2): 315-323. doi: 10.1016/0008-6215(91)80038-O
-
[26]
Pustylnikov S., Sagar D., Jain P., Khan Z. K.. Targeting the C-type lectins-mediated host-pathogen interactions with dextran[J]. J. Pharm. Pharm. Sci., 2014, 17(3): 371-392. doi: 10.18433/J3N590
-
[27]
Zhou S., Dou H., Zhang Z., Sun K., Jin Y., Dai T., Zhou G., Shen Z.. Fluorescent dextran-based nanogels:efficient imaging nanoprobes for adipose-derived stem cells[J]. Polym. Chem., 2013, 4(15): 4103-4112. doi: 10.1039/c3py00522d
-
[28]
Zhou S., Min X., Dou H., Sun K., Chen C. Y., Chen C. T., Zhang Z., Jin Y., Shen Z.. Facile fabrication of dextran-based fluorescent nanogels as potential glucose sensors[J]. Chem. Commun., 2013, 49(82): 9473-9475. doi: 10.1039/c3cc45668d
-
[29]
Wang H., Dai T., Zhou S., Huang X., Li S., Sun K., Zhou G., Dou H.. Self-assembly assisted fabrication of dextran-based nanohydrogels with reduction-cleavable junctions for applications as efficient drug delivery systems[J]. Sci. Rep., 2017, 7: . doi: 10.1038/srep40011
-
[30]
Li Q. L., Gu W. X., Gao H., Yang Y. W.. Self-assembly and applications of poly (glycidyl methacrylate)s and their derivatives[J]. Chem. Commun., 2014, 50(87): 13201-13215. doi: 10.1039/C4CC03036B
-
[31]
Sousani A., Moghadam P. N., Hasanzadeh R., Motiei H., Bagheri M.. Synthesis of poly glycidylmethacrylate grafted azobenzene copolymer:photosensitivity and nonlinear optical properties[J]. Opt. Mater., 2016, 51: 232-240. doi: 10.1016/j.optmat.2015.11.006
-
[32]
Lauffer R. B.. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging:theory and design[J]. Chem. Rev., 1987, 87(5): 901-927. doi: 10.1021/cr00081a003
-
[33]
Zheng J. P., Liu Q. L., Zh en, M. M., Jiang F., Shu C. Y., Jin C., Yang Y., Alhadlaq H. A., Wang C. R.. Multifunctional imaging probe based on gadofulleride nanoplatform[J]. Nanoscale, 2012, 4(12): 3669-3672. doi: 10.1039/c2nr30836c
-
[34]
Borges M., Yu S., Laromaine A., Roig A., Suárez-García S., Lorenzo J., Ruiz-Molina D., Novio F.. Dual T1/T2 MRI contrast agent based on hybrid SPION@coordination polymer nanoparticles[J]. RSC Adv., 2015, 5(105): 86779-86783. doi: 10.1039/C5RA17661A
-
[35]
Park J. Y., Kim S. J., Lee G. H., Jin S., Chang Y., Bae J. E., Chae K. S.. Various ligand-coated ultrasmall gadolinium-oxide nanoparticles:water proton relaxivity and in-vivo T1 MR image[J]. J. Korean Phys. Soc., 2015, 66(8): 1295-1302. doi: 10.3938/jkps.66.1295
-
[36]
Le W., Cui S., Chen X., Zhu H., Chen B., Cui Z.. Facile synthesis of Gd-functionalized gold nanoclusters as potential MRI/CT contrast agents[J]. Nanomaterials, 2016, 6(4): . doi: 10.3390/nano6040065
-
[37]
Zhang J., Hao G., Yao C., Hu S., Hu C., Zhang B.. Paramagnetic albumin decorated CuInS 2/ZnS QDs for CD133+ glioma bimodal MR/fluorescence targeted imaging[J]. J. Mater. Chem. B, 2016, 4(23): 4110-4118. doi: 10.1039/C6TB00834H
-
[38]
Della Rocca J., Liu D., Lin W.. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery[J]. Acc. Chem. Res., 2011, 44(10): 957-968. doi: 10.1021/ar200028a
-
[39]
Favier A., D'Agosto F., Charreyre M. T., Pichot C.. Synthesis of N-acryloxysuccinimide copolymers by RAFT polymerization, as reactive building blocks with full control of composition and molecular weights[J]. Polymer, 2004, 45(23): 7821-7831. doi: 10.1016/j.polymer.2004.09.042
-
[40]
Chen Z., Yu D., Liu C., Yang X., Zhang N., Ma C., Song J., Lu Z.. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent[J]. Drug Target., 2011, 19(8): 657-665. doi: 10.3109/1061186X.2010.531727
-
[41]
Liu Q., Song L., Chen S., Gao J., Zhao P., Du J.. A superparamagnetic polymersome with extremely high T2 relaxivity for MRI and cancer-targeted drug delivery[J]. Biomaterials, 2017, 114: 23-33. doi: 10.1016/j.biomaterials.2016.10.027
-
[42]
Song S., Guo H., Jiang Z., Jin Y., Wu Y., An X., Zhang Z., Sun K., Dou H., Dou H.. Self-assembled microbubbles as contrast agents for ultrasound/magnetic resonance dual-modality imaging[J]. Acta Biomater., 2015, 24: 266-278. doi: 10.1016/j.actbio.2015.06.025
-
[1]
-
扫一扫看文章
计量
- PDF下载量: 0
- 文章访问数: 2252
- HTML全文浏览量: 43

下载: